This site is intended for healthcare professionals only
LoginRegister
GSK gets European Commission marketing authorisation for Jemperli, chemotherapy combo for endometrial cancerGSK gets European Commission marketing authorisation for Jemperli, chemotherapy combo for...
Budget Quotes - Mankind Pharma, Bharat Serum and Vaccines & Park Medi WorldChrysCapital, Capital Group sell 7.6 percent stake in Mankind Pharma for Rs 5589 crore
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare Bengaluru unit gets TGA Australia nod for manufacturing medicinal Oral Mouth...
Granules India bags USFDA nod for Pantoprazole Sodium Delayed Release TabletsGranules India bags USFDA nod for Pantoprazole Sodium Delayed Release Tablets
Granules India gets USFDA EIR for Bonthapally facilityUSFDA inspection: Laurus Labs arm gets 5 observations for AP facility
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche Gets CDSCO Panel Nod to Study anti-cancer Drug Inavolisib
Merck Animal Health receives positive CVMP opinion for injectable formulation of Bravecto for dogsMerck Animal Health receives positive CVMP opinion for injectable formulation of Bravecto for dogs
Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USAAstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoidSanofi terminates deal to exclusively license Maze Therapeutics Pompe disease drug
Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspectionTorrent Pharma gets 5 USFDA observations for Gujarat facility
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb, SystImmune collaborate for development, commercialization of BL-B01D1
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer Marstacimab regulatory submissions for treatment of Hemophilia A and B accepted by USFDA, EMA
X